Daiwa Securities Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Daiwa Securities Group’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-195	Closed	-$2K	–	1312
2020 Q3	$2K	Hold	195	–	–	﹤0.01%	1155
2020 Q2	$1K	Hold	195	–	–	﹤0.01%	1202
2020 Q1	$1K	Hold	195	–	–	﹤0.01%	1206
2019 Q4	$2K	Hold	195	–	–	﹤0.01%	1180
2019 Q3	$2K	Hold	195	–	–	﹤0.01%	1143
2019 Q2	$2K	Hold	195	–	–	﹤0.01%	1164
2019 Q1	$3K	Hold	195	–	–	﹤0.01%	1120
2018 Q4	$3K	Hold	195	–	–	﹤0.01%	1100
2018 Q3	$4K	Hold	195	–	–	﹤0.01%	1098
2018 Q2	$4K	Hold	195	–	–	﹤0.01%	1114
2018 Q1	$4K	Buy	+195	New	+$3.3K	﹤0.01%	1097

Daiwa Securities Group's AMAG Position: Q4 2020 in Review

Daiwa Securities Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 195 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in AMAG in Q1 2018 and held it in 11 quarters. The position peaked at $4K in Q3 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

Daiwa Securities Group reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Daiwa Securities Group sold 195 AMAG Pharmaceuticals shares in Q4 2020, an estimated $2K.
Daiwa Securities Group first reported a position in AMAG Pharmaceuticals in Q1 2018 and held it in 11 quarters.
Daiwa Securities Group's AMAG Pharmaceuticals position peaked at $4K in Q3 2018.
1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.